Archived Newsletters
-
06.05.26 -- Biologics Development Insights: Cell Lines, ADCs & Scalable Manufacturing
6/5/2026
06/05/26 Outsourced Pharma Newsletter
-
06.05.26 -- New Podcast Episodes: Validation Challenges, Rare Disease Drug Commercialization, Redefining CAR-T Timing, and More
6/5/2026
06/05/26 Outsourced Pharma Newsletter
-
06.05.26 -- FDA Now A Supply-Chain Complication
6/5/2026
06/05/26 Outsourced Pharma Newsletter
-
06.04.26 -- FDA Now A Supply-Chain Complication
6/4/2026
06/04/26 Outsourced Pharma Newsletter
-
06.03.26 -- From Gene to GMP: Solving Advanced Therapy's Toughest Manufacturing Challenges
6/3/2026
06/03/26 Outsourced Pharma Newsletter
-
06.03.26 -- BIOSECURE Act And The 8 Supply-Chain Lessons Sponsors Can't Ignore
6/3/2026
06/03/26 Outsourced Pharma Newsletter
-
06.02.26 -- Advancing Precision And Scale Across Genetic Medicine
6/2/2026
06/02/26 Outsourced Pharma Newsletter
-
06.02.26 -- Navigating Combination Product Development For Novel Biologics
6/2/2026
06/02/26 Outsourced Pharma Newsletter
-
06.02.26 -- Can A Biotech Create A CDMO Market?
6/2/2026
06/02/26 Outsourced Pharma Newsletter
-
06.01.26 -- Cut Variability, Raise Titers, And Scale With Confidence
6/1/2026
06/01/26 Outsourced Pharma Newsletter